Skip to main content

New collection: Advances in CAR-T immunotherapy

Chimeric antigen receptor (CAR) T cells therapies, as a novel modality in cancer immunotherapy, provide a quantum leap in the treatment of cancer.  BMC Cancer and BMC Biotechnology together present the latest collection of articles on the advances in CAR-T immunotherapy covering the entire range of advances from lab to clinic. Click on highlight to read the the full collection of articles. 

August: Health Disparities

New Content Item


With World Humanitarian Day falling on 19th August, the BMC Series decided to focus on health disparities in August’s focus issue. Browse our biology, chemistry and medical titles for insight into health disparities, including racial health disparities, socioeconomic health disparities and regional disparities

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last 6 months!

Articles

Featured review: Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico

Gallbladder cancer is a rare malignancy of the biliary tract with a poor prognosis, frequently presenting at an advanced stage. While rare in the United States overall, gallbladder cancer has an elevated incidence in geographically distinct locations of the globe including Chile, North India, Korea, Japan and the state of New Mexico in the United States. Rama R. Gullapalli, Associate Editor for BMC Cancer provides this review.

Featured video: Microparticles, breast cancer's secret weapon?

Your browser needs to have JavaScript enabled to view this video

Read the article

Featured review: A stepwise approach to constructing systematic reviews

New Content ItemSystematic reviews, with or without meta-analysis, play an important role today in synthesizing cancer research and are frequently used to guide decision-making. With a focus on cancer, first author, Prof Kelley, provides a practical, stepwise approach for systematically reviewing the literature and publishing the results. 

Read More

Featured article: Are cancer patients better off if they participate in clinical trials?

How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.

Aims and scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Journal Sections


Editor
Linda Gummlich, BMC Series, London, UK

Manuscript Editor

Dylan Smith, BMC Series, London, UK

Assistant Editor

Catherine Rice, Senior Assistant Editor, BMC Series, London
 

Consulting Editors
Yanis BoumberFox Chase Cancer Center, USA
Ken Herrmann, Universitätsklinikum Essen, Germany
Alan Lefor, Jichi Medical University, Japan
Christophe Nicot, Kansas University Medical Center, USA
Stephen Povoski, The Ohio State University, USA
Dirk Vordermark, Martin Luther University Halle-Wittenberg, Germany

Cross-journal thematic series: Precision Oncology

We are proud to finally present the publications from our cross-journal thematic series, Precision Oncology. This collection focuses on how precision oncology has shaped advances in the impact of non-coding RNAs in epigenetics and cancer, immunotherapy and tumor biology. Also of note are the technological developments for preclinical routines and the clinical significance of various therapies in breast, esophageal, liver, lung, ovarian cancers, among other types.

Read our highly accessed articles

New Content ItemEGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

New Content ItemEstimation of immune cell content in tumor using single-cell RNA-seq reference data

New Content ItemDynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study​​​​​​​

Editorial: Nobel Prize Cancer Immunotherapy!

Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...

Latest Tweets

2019 Journal Metrics

  • Citation Impact
    3.15 -   2-year Impact Factor
    3.432 - 5-year Impact Factor
    1.021 - Source Normalized Impact per Paper (SNIP)
    1.186 - SCImago Journal Rank (SJR)

    Usage 

    4,151,734 downloads

    Social Media Impact 

    3364 mentions